SCHEMBL46523

SCHEMBL46523

NC(=O)c1cccc2[nH]ccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
ATM Q13315 1/20 0.59
PDPK1 O15530 1/20 0.53
PARP1 P09874 2/20 0.50
DHPS P49366 1/20 0.49
TUBB4A P04350 1/20 0.49
TUBB P07437 1/20 0.49
TUBA3C P0DPH7 1/20 0.49
TUBA1B P68363 1/20 0.49
TUBA4A P68366 1/20 0.49
TUBB4B P68371 1/20 0.49
TUBB3 Q13509 1/20 0.49
TUBB2A Q13885 1/20 0.49
TUBB8 Q3ZCM7 1/20 0.49
TUBA3E Q6PEY2 1/20 0.49
TUBA1A Q71U36 1/20 0.49
TUBA1C Q9BQE3 1/20 0.49
TUBB6 Q9BUF5 1/20 0.49
TUBB2B Q9BVA1 1/20 0.49
TUBB1 Q9H4B7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16796081 0.98 ALDH1A1 (0.58) ALDH1A1ATMPDPK1PARP1DHPS
SCHEMBL3824876 0.86 ALDH1A1 (0.49) ALDH1A1ATMPDPK1PARP1DHPS
SCHEMBL25668829 0.85 ALDH1A1 (0.47) ALDH1A1ATMPDPK1PARP1DHPS
SCHEMBL9795027 0.84 NUDT1 (0.61) ALDH1A1ATMPDPK1PARP1MAPK1
SCHEMBL29822224 0.84 NUDT1 (0.61) ALDH1A1ATMPDPK1PARP1MAPK1
SCHEMBL40257 0.82 NAPRT (0.52) ALDH1A1PARP1DHPSTUBB4ATUBB
SCHEMBL29684913 0.82 NAPRT (0.52) ALDH1A1PARP1DHPSTUBB4ATUBB
SCHEMBL23046869 0.81 MAPK1 (0.49) ALDH1A1ATMPDPK1DHPSTUBB4A
Hydrochloric Acid SCHEMBL1374882 0.81 KEAP1 (0.50) ALDH1A1PARP1DHPSTUBB4ATUBB
SCHEMBL31409739 0.81 MAPK1 (0.57) ALDH1A1ATMPDPK1DHPSTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108174603-A 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators for the treatment or prevention of disorders related thereto 阿芮纳制药有限公司 2018-06-15 CN claimed
CN-104768946-B Fused pyrimidines as inhibitors of the p97 complex 克里弗生物科学公司 2017-05-03 CN claimed
CN-106458996-A Fused pyrimidines as inhibitors of the p97 complex 克里弗生物科学公司 2017-02-22 CN claimed
EP-3080101-A1 MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX Cleave Biosciences, Inc. (US) 2016-10-19 EP claimed
WO-2016161570-A1 AZACARBAZOLE BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-10-13 WO claimed
WO-2015089218-A1 MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX WUSTROW DAVID (US) 2015-06-18 WO claimed
CN-102325752-B Carbazole and carboline kinase inhibitors BRISTOL MYERS SQUIBB CO 2015-02-04 CN claimed
EP-2766344-A1 EP1 RECEPTOR LIGANDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2014-08-20 EP claimed
EP-2651919-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-10-23 EP claimed
WO-2013037960-A1 EP1 RECEPTOR LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-03-21 WO claimed
WO-2011140324-A1 INDOLES GLAXOSMITHKLINE LLC (US) 2011-11-10 WO claimed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP claimed
EP-2231143-A1 INHIBITORS OF JANUS KINASES Merck Sharp & Dohme Corp. (US) 2010-09-29 EP claimed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO claimed
WO-2009075830-A1 INHIBITORS OF JANUS KINASES MERCK & CO., INC. (US) 2009-06-18 WO claimed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 WO claimed
WO-2008154129-A1 PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING, REDUCING, AMELIORATING, ALLEVIATING, OR PREVENTING DRY EYE BAUSCH & LOMB INCORPORATED (US) 2008-12-18 WO claimed
EP-1327632-B1 METHOD FOR PRODUCING TRIMER OF INDOLE DERIVATIVE, AND TRIMER OF INDOLE DERIVATIVE AND LAMINATED STRUCTURE THEREOF MITSUBISHI RAYON CO (JP) 2008-12-03 EP claimed
CN-101203244-A Compositions of rennin inhibitor and insulin secernent or insulin sensitizer NOVARTIS AG (CH) 2008-06-18 CN claimed
CN-101163504-A Combination therapy XENON PHARMACEUTICALS INC (CA) 2008-04-16 CN claimed